This forum carries on the summary in a higher stratification plane to some domain's research condition, will provide the direction for present's research, and will instruct its research the application prospect; Meanwhile conducts the depth research to the important basic research question of cardiovascular disease to summarize, unfolds some specific research work's development and the newest research results reported and excavates some new luminescent spot theme and the new sharp scholar's academic thought.
The current progress of researches into the mechanism of pulmonary hypertension; The promotion of the new idea of aim-targeted treatment in 2008; The interventional treatments in both pulmonary thrombosis and venous thrombosis; Integration of interventional treatments in tachyarrhythmias of pulmonary hypertension; Examination through arms of right-sided cardiovascular and analysis of the feasibility of pulmonary angiography and the preliminary results of 50 cases; The latest progress in treatment of rheumatic-related pulmonary hypertension; The symposium of Pulmonary Vascular Disease & Right-sided Heart Failure is sure to bring about some brand new ideas in related areas nationwide.
Forum on Heart & Kidney
The symposium begins with kidney-related diseases in cardiovascular treatment, and discusses on such basic clinical issues and researches as heart and kidney anemia syndrome, contrast-induced nephropathy, hypertension combined heart and kidney damage, and treatments of anticoagulant and antiplatelet on patients with cardiovascular disease and chronic kidney disease.
Forum on Cardiovascular Imaging
Ranty Martin, former president of American Society of Echocardiography (ASE) from Emory University, is invited to give a speech on the advances and orientation of echocardiography research. Other participants invited include professionals in echocardiography from home and America, who will be evaluating on the clinical value of technologies such as dot-tracking, myocardial contrast echocardiography (MCE), and real-time 3D echocardiography through esophagus. It is also our great honor to have Prof. Gong yuan Xie, from University of Missouri, and Prof. Jie Jane Cao, from Stony Brook University, to lecture with clinical cases on appropriate applications of Coronary CT and Cardiac Magnetic Resonance Imaging in diagnosis of cardiovascular diseases, as to provide some suggestions on better utility of clinical resources.
Forum on Angina Pectoris
This symposium continues to attach importance to clinical relevance, introducing to surgeons technology and its development most relevant to clinical work. In order to further understanding of diseases, the symposium will on one hand elaborate on biochemical indicators and non-invasive screening technology in the diagnosis of angina, and on the other explain with specific cases the main points of treatment surgeons most interested in. Share with success, and learn from failure.
Forum on Medicine as a Whole
How to assess diseases with full understanding and rationality and provide with patients the most appropriate treatment? And for those who want to become a professional physicist, how to strengthen the communication with patients, accurately pointing to the intrinsic nature of disease from descriptive words by patients, and in what ways can they find more access to promote health awareness of the public and reduce probability and severity of diseases? Issues as mentioned will be discussed in depth in the symposium of Medicine as a Whole @ GW-ICC. We hope to build up a platform for multidisciplinary communications, and provide possible solutions to clinical problems from different angles and dimensions.
Forum on Psycho-cardiology
Psycho-cardiology is an integrated science of cardiovascular division and psychiatry, symposium on which aims at looking for the combination of scientific understanding toward life and humanity toward individuals, making efforts in exploration of a combination of Humanity & Medicine. Psycho-cardiology respects individual feelings in the practice of medical treatment, looks for various methods to improve the prognosis, and avoids iatragenic disease due to excess reliance on technologies.
Translational Medicine Forum
Advances in cardiovascular therapies, as in all of clinical medicine, are made through a process whereby new ideas and inventions are conceived, tested for proof-of-concept, efficacy, and safety in the laboratory setting, then assessed in clinical trials. Should a novel drug, device, or biotechnology approach reach all these milestones successfully, being adequately supported with the necessary funding along the way, then new and better treatments are made available to physicians. This process is called "translational research" because the initial ideas, inventions, or discoveries are gradually and sequentially translated into novel therapies. The value of basic scientific discoveries in biology is unquestioned and remains a fundamental foundation of medicine, but it is in translational research where the value of such discoveries for the advancement of human health is realized.
